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A specific method for the rapid assay of muscarinic acetylcholine r ceptors (mAChR), either detergent-solu- 
bilized or in neuroblastoma cells, is described. This method is also applicable to the assay of nicotinic acetyl- 
choline receptors. The procedure employs a cell harvestor and microtiter plates, and has the advantage of 
requiring small quantities of radioligand, microgram quantities of detergent-solubilized cholinergic receptor 
or less cells. The binding parameters such as the equilibrium dissociation constants (Kd) of mAChR and 
nicotinic acetylcholine r ceptor (nAChR) and inhibition constants (Ki) for antagonists determined by the 
present method are in excellent agreement with values determined by other methods. This assay procedure 
for mAChR and nAChR should facilitate the rapid screening of cholinergic agonists/antagonists andalso 
the further purification and characterization of mAChR. 
Muscarinic acetylcholine r ceptor; Nicotinic acetylcholine r ceptor; Cell harvestor; Detergent solubilization 
1. INTRODUCTION 
Quantitative assay of radiolabeled ligands 
bound to solubilized mAChRs requires the 
availability of an assay to determine the relative 
concentrations of bound and/or free ligand. Until 
now, mAChR has been measured by equilibrium 
dialysis [1], charcoal precipitation [2,7], DEAE 
cellulose adsorption [3,4,5], ammonium sulfate 
precipitation [5,6], gel permeation [8], and PEG 
precipitation [3,7]. Assays employing PEG-6000 or 
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ammonium sulfate to precipitate the receptor- 
ligand complex, which is collected onto glass-fiber 
filters (mounted on an Amicon vacuum manifold) 
are time consuming, and only a limited number of 
assays can be accomplished each day. The 
equilibrium dialysis and gel filtration procedures 
are even more cumbersome if a large number of 
samples are to be analyzed. The assay of mAChR 
by DEAE-filter disk is dependent on the retention 
of the receptor-ligand complex on anion-exchange 
disks followed by removal of the unbound 
radioligand by washing the disks, usually by 
tumbling in a beaker. However, removal of the un- 
bound ligand is not efficient by the latter pro- 
cedure, and background retention of the 
radioligand tends to be higher. Moreover, con- 
siderable fragmentation of the paper disks is in- 
evitable, making quantitative transfer of the disks 
difficult. 
In this report, we describe the use of a cell 
harvestor and a 96-well tissue culture plate to 
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facilitate rapid separation of PEG precipitated 
ligand-receptor complex. The assay procedure pro- 
vides a rapid, efficient, and microtechnique for 
studying ligand binding to solubilized mAChR and 
nAChR. 
2. MATERIALS AND METHODS 
2.1. Reagents 
Tritium labeled N-methylscopolamine ([3H]- 
NMS; 72 Ci/mmol) was purchased from Dupont- 
New England Nuclear and ce-[3H]bungarotoxin 
(93 Ci/mmol) was purchased from Amersham. 
EDTA, bovine serum albumin, PEG 6000, digito- 
nin (lot no.124F-0261), PMSF, sodium azide, and 
atropine were purchased from Sigma. Unlabeled 
c~-bungarotoxin was purchased from Boehringer 
Mannheim. The remaining chemicals were the 
highest quality commercially available. 
2.2. Preparation of bovine brain membranes 
Bovine brain membranes were prepared from 
frozen brain as described by Haga and Haga [9] 
with minor modifications. All procedures were 
carried out at 0-4°C.  Briefly, 800 g of frozen 
bovine brain was thawed and homogenized in 2 1 
of buffer A (50 mM potassium phosphate, pH 7.2, 
0.1 mM EDTA, 0.1 mM PMSF and 0.02% 
sodium azide). The suspended tissue was 
homogenized in a Waring blender, and the 
homogenate was centrifuged at 16000 x g for 1 h. 
The pellet was resuspended in 2 1 of buffer A and 
again centrifuged at 16000 x g for 1 h. The pellet 
was resuspended in buffer A containing 2 M 
sucrose to make the final sucrose concentration 
0.8 M and a final volume of 1.35 1. The suspension 
(50ml/tube) was layered over 1.14M sucrose 
(10 ml/tube) in centrifuge tubes and centrifuged at 
235000 x g for 1 h. The layer at the interface be- 
tween 0.8 and 1.14M sucrose was collected, 
homogenized with a Waring blender, and stored at 
-70°C until the next step. 
2.3. Muscarinic receptor solubilization procedure 
The homogenate containing mAChR of the 
previous tep was solubilized with digitonin by ad- 
ding an equal volume of buffer A containing 2°70 
digitonin. The suspension was shaken for 1 h and 
centrifuged at 47000 x g for 1 h. The pellet was 
again extracted with buffer A containing 2070 
digitonin and the suspension centrifuged again at 
47000 x g for 1 h. The supernatant collected after 
the second extraction contained the mAChR activi- 
ty. The fraction from the second extraction was 
considered the solubilized mAChR because further 
centrifugation at 106000 x g did not decrease the 
mAChR activity in the supernatant. 
2.4. Nicotinic receptor solubilization procedure 
Soluble nAChR was prepared from the frozen 
electric organ of Torpedo californica essentially as 
described by Lindstrom et al. [18]. Briefly, the 
electric organ was homogenized in a buffer con- 
taining 0.1 M sodium chloride, 0.01 M sodium 
phosphate buffer (pH 7.5), 0.01 M sodium azide, 
0.01 M EDTA, 0.01 M ethylene-bis(oxyethylene- 
nitrile)tetraacetic acid, 0.01 M iodoacetamide, 
0.001 M PMSF at room temperature for 1 min in 
a Waring blender. The homogenate was centri- 
fuged at 100000 x g for 30 min and the pellet was 
collected and solubilized using sodium cholate as 
the detergent (final concentration, 1 °70) at 4°C for 
lh .  
2.5. Binding assays 
2.5.1. mAChR 
[3H]NMS binding to purified membranes or 
N4TG1 neuroblastoma cells and solubilized recep- 
tor was carried out in 96-well tissue culture plates 
at 25°C in a final volume of 0.15 ml. The concen- 
tration of [3H]NMS typically was 2 nM and non- 
specific binding was determined in the presence of 
1/zM atropine. To assay for the ligand binding to 
cells, approx. 5-50 x 104 cells were added to each 
well. To determine the ligand binding to mem- 
branes or soluble mAChR, less than 400/zg of pro- 
tein were added to each well. The plates were then 
placed on a mechanical rocker for 1 h to mix and 
incubated at 25°C. 
2.5.2. nAChR 
cr-[3H]Bungarotoxin binding to solubilized 
nAChR was assayed in tissue culture plates at 4°C 
as described for the mAChR. For Scatchard 
analysis [11], the cr-[3H]bungarotoxin concentra- 
tion ranged from 0.1 to 50 nM, and the protein 
concentration was approx. 0.018 mg in 0.15 ml per 
96 well. The incubation period was 20-24 h. The 
non-specific binding was determined in the 
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presence of 10/zM cold a,-bungarotoxin. The in- 
cubation system also included 0.2 mg of bovine 
serum albumin. 
2.6. Harvesting of  samples 
The contents of the wells were harvested with a 
semi-automated cell harvestor which can harvest 2 
rows (24 samples) of the 96-well plate in 30 s 
(Cambridge Technology, Cambridge, MA) onto 
glass-fiber filters (grade 934 AH, Cambridge 
Technology). In the case of cells or membranes, 
after harvesting, the filters were quickly washed 
with 24 ml of phosphate buffered saline (PBS, 
50 mM potassium phosphate, pH 7.2, and 0.9% 
sodium chloride (w/v), 1 ml/well). With respect o 
soluble mAChR or nAChR, prior to harvesting, 
0.15 ml of ice-cold 25% (w/v) PEG-6000 (final 
concentration was 12.5%) in PBS was added to 
each well to precipitate the receptor-ligand com- 
plex and the plate was placed at 4°C for 5-10 rain. 
Then the samples were harvested and the glass- 
fiber filters were washed quickly with 24 ml of 
12.5°/0 (w/v) ice-cold PEG-6000 (1 ml/well). The 
dried filter disks were placed into minivials and 
5 ml of Hydroflour was added prior to scintillation 
counting. 
Solubilized mAChR was also assayed by the 
Sephadex G-25 gel filtration assay. Samples 
(0.15 ml) were applied to a Sephadex G-25 column 
(4 ml bed volume, Bio-rad Econo-Column). The 
receptor-ligand complex was eluted by the addition 
of 2.0 ml of PBS and collected irectly into a scin- 
tillation vial and counted by adding 20 ml of 
Hydroflour. Protein was determined according to 
the procedure described by Lowry et al. [10] and 
bovine serum albumin was used as the standard. 
3. RESULTS 
3.1. Effect of  PEG concentration on the 
precipitation of receptor-ligand complex 
(PEG cell harvestor assay) 
To optimize [3H]NMS-receptor complex 
precipitation by PEG, the polyethylene glycol con- 
centration was varied. Quantitative precipitation 
of the [3H]NMS-receptor complex occurred at 
PEG concentrations equal to or greater than 
12.5% (fig.l). The minimum time required was 
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Fig. 1. Effect of PEG (panel A) and digitonin (panel B) 
on the precipitation of [3H]NMS-receptor complex. 
Percentage precipitation values (ordinate) were 
calculated by dividing the dpm value for each treatment 
point by the dpm value obtained at 12.5% PEG with 
0.6% digitonin. Each data point is the mean + SD of 
triplicate samples. The concentration of [3H]NMS was 
2 nM and assay conditions were as described in 
section 2. 
3.2. Effect of digitonin concentration on binding 
of  [~H]NMS to solubilized bovine brain 
mA ChR 
When digitonin-solubilized bovine brain 
mAChR was incubated with 2 nM [3H]NMS and 
varying concentrations of digitonin (0.6-1.4%, 
w/v), the binding activity of [3H]NMS to the 
mAChR decreased with increasing concentration 
of digitonin (fig.l). At 1.4% digitonin, a 50% 
decrease in ligand binding occurred. This result in- 
dicates that [3H]NMS binding to the mAChR 
receptor could be detected at a high concentration 
of digitonin by the PEG cell harvestor assay, 
although digitonin is inhibitory to the binding 
process. 
3.3. Effect of receptor protein concentration 
[3H]NMS binding to digitonin-solubilized 
mAChR was linear between 77 and 385/tg of pro- 
tein (not shown). Thus, the PEG cell harvestor 
assay described here was quantitative for the 
receptor-ligand complex precipitated from 
digitonin buffers. 
3.4. Interaction of solubilized mAChR with 
fH]NMS as studied by the PEG cell 
harvestor assay and comparison with other 
methods 
Scatchard analysis [11] of [3H]NMS binding to 
receptors at 25°C produced a dissociation constant 
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Table 1 
Comparison of equilibrium dissociation constants (K~) obtained by 
different assay methods a 
Assay method 
Cell harvestor Sephadex G-25 Literature 
gel filtration values 
Kd (nM) 0.20 _+ 0.02 b 0.13 +_ 0.02 c 0.2 [7], 0.4 [13], 
0.2 [12], 0.52 [9] 
Bmax (fmol/mg 
protein) 0.21 _ 0.02 0.24 _+ 0.03 - 
Saturation binding assays were performed as described in section 2, 
using the cell harvestor or Sephadex G-25 gel filtration. Varying 
concentrations of [3H]NMS were incubated with solubilized 
receptor for 1 h at 25°C. Kd values were obtained according to the 
method of Munson and Rodbard [14] 
b Mean + SD of quadruplicate assays 
c Mean +_ SD of duplicate assays 
(Ko) of 0.20 nM for the PEG cell harvestor assay 
and 0.13 nM for the Sephadex G-25 fi ltration 
assay. The results for the two methods are in ex- 
cellent agreement (table 1). These values are in 
agreement with values obtained from the charcoal 
adsorption [7], manifold fi ltration [12,13], and 
equil ibrium dialysis [7] methods. In addition, the 
non-specific binding of radiol igand was 5 -10% of 
the total counts by the PEG cell harvestor and gel 
f i ltration procedure. 
Table 2 
Potencies of muscarinic receptor antagonists inhibiting [3H]NMS binding to cell 
surface or detergent solubilized mAChR 
mAChR Ki (nM) a 
antagonists 
Cell harvestor assay bx Literature values 
Bovine brain N4TG1 d Membrane Solubilized 
solubilized neuroblastoma bound mAChR 
mAChR cell mAChR mAChR 
Atropine 1.6 + 0.2 2.4 + 0.7 2.5 [12] 1.98 [8] 
2.0 [5] 1.20 [9] 
QNB 1.3 +_ 0.2 0.5 + 0.2 - 1.43 [5] 
a The ICs0 values were first determined using ALLFIT, a computer program for 
the analysis of inhibition curves [14]. Ki values were calculated from the ICs0 
values (ICs0 is the dose of drug which inhibits 50% of the binding of the 
radioactive ligand) according to the calculations of Cheng and Prusoff [15], 
where Ki = ICso × (1 + ([3H]ligand/Ka) 
b Mean + SD of triplicate assays 
The concentration f [3H]NMS was 2 nM and assay duration was 1 h at 25°C 
a N4TG1 neuroblastoma cells (5 × 105 cells/well) were cultured and prepared 
in Hanks media containing 25 mM Hepes (pH 7.3) as described [16,17] 
288 
Volume 214, number 2 FEBS LETTERS April 1987 
3.5. Inhibition of l~H]NMS binding to mAChR by 
atropine and QNB 
The ability of two muscarinic antagonists to 
compete for N4TGI neuroblastoma cell bound or 
solubilized [3H]NMS binding sites was determined. 
The muscarinic antagonists atropine and QNB in- 
hibited [3H]NMS binding to bovine brain solubi- 
lized mAChR with Ki values determined by the 
PEG cell harvestor assay of 1.6 and 1.3 nM, 
respectively, and agreed well with the findings of 
other investigators (table 2). Furthermore, atro- 
pine inhibited the binding of [3H]NMS to cell sur- 
face mAChR of N4TG1 neuroblastoma cells with 
a Ki value of 2.4 nM, which compares favorably to 
values reported for membrane bound mAChR 
(table 2). 
3.6. nAChR assay by the PEG cell harvestor 
method 
The PEG cell harvestor assay procedure should 
have general applicability to soluble receptors. By 
Scatchard analysis of the soluble nAChR, a Kd 
value of 0.57 _+ 0.06 nM was determined using the 
PEG cell harvestor assay. This Kd value is in ex- 
cellent agreement with literature values, which 
range from 0.14 to 0.96 [19,20] for the nAChR 
from electric organs and determined by other 
methods than the PEG cell harvestor assay. 
4. DISCUSSION 
The present assay method, using a cell harvestor 
and 96-well tissue culture plate and PEG for 
measuring detergent-solubilized mAChR has 
several advantages over more conventional assay 
techniques. First, the receptor protein is pipetted 
only once directly into each well, thereby minimiz- 
ing the manual handling errors associated with 
other methods. Second, only microgram quantities 
of receptor protein are required for each well. 
Third, consumption of expensive radioligand 
materials is minimized. Fourth, a large number of 
receptor assays can be performed and managed 
quickly and efficiently. Fifth, this assay is very 
useful when large numbers of drugs are screened 
for their potential as anticholinergic agents or as 
agonists. Sixth, the system can be set up rapidly, 
conveniently, and inexpensively. Additionally, this 
procedure should be applicable to the quantitative 
determinations of other soluble receptors. With 
respect to another soluble receptor, the nAChR 
can be assayed by this procedure and the Kd value 
agrees well with literature values. 
However, there is a caution associated with the 
use of the cell harvestor. The small amounts of 
ceils (5-50 × 10 4 cells/well) or solubilized receptor 
that can be used without clogging the glass-fiber 
filters may pose a problem if few receptor sites are 
present in the tissue or solubilized preparation. In 
conclusion, the development of this simple and 
rapid assay procedure for the soluble receptors 
should facilitate the examination of the effects of 
many cholinergic receptor agonists or antagonists, 
and the further purification and characterization 
of the mAChR. 
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